Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
HCM similar filings
- 3 Jan 22 Current report (foreign)
- 20 Dec 21 Current report (foreign)
- 15 Dec 21 Grant of Share Options under Share Option Scheme and Awards under
- 14 Dec 21 HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting
- 10 Dec 21 HUTCHMED Highlights Surufatinib and Toripalimab Combination Clinical Data being Presented at the ESMO Immuno-Oncology 2021 Meeting
- 6 Dec 21 HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
- 3 Dec 21 HUTCHMED Announces Agreement with NHSA for Continued Inclusion of ELUNATE® and Addition of SULANDA® in the National Reimbursement Drug List in China
Filing view
External links